OncoEMR® Toolkit: Simplify CLL Tracking in Oncology Practices

OncoEMR® Toolkit: Simplify CLL Tracking in Oncology Practices

The OncoEMR Toolkit provides oncology practices with step-by-step guidance to identify, evaluate, and monitor CLL patients who may benefit from BRUKINSA—directly within OncoEMR.

What you can do with this toolkit:

• Generate Patient Lists: Use the Patient Staging Analysis report with CLL-specific filters and ICD codes to quickly identify eligible patients.
• Assess Eligibility: Review treatment history, molecular markers (TP53, del[17p]), comorbidities, performance status, and tolerance to prior BTK inhibitors.
• Streamline Chart Reviews: Navigate via the vertical toolbar to quickly access oncology diagnoses, provider notes, and lab trends.
• Create Activities:
  • Build a “BRUKINSA eligibility review” activity.
  • Integrate directly into treatment plans and flowsheets.
  • Document eligibility, rationale, and follow-up reminders in the patient chart.
• Enhance Team Collaboration: Share insights in tumor boards or pharmacy rounds and integrate alerts into pathways for consistent patient evaluation.

With the OncoEMR toolkit, oncology teams can standardize workflows, improve continuity of care, and maintain focus on high-quality patient outcomes.

Download Toolkit